TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma.

A F Herrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.